electroCore to Participate in Upcoming Investor Conferences
electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, has announced its participation in two upcoming investor conferences. CEO Dan Goldberger will attend the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference from August 12-13, 2024. Interested parties can contact Needham to schedule one-on-one meetings.
Additionally, CFO Brian Posner will be present at the 44th Annual Canaccord Genuity Growth Conference at the InterContinental Hotel in Boston, MA. electroCore will host investor meetings on August 13, 2024. To arrange a meeting, interested parties should contact Canaccord Genuity.
These conferences provide electroCore with opportunities to engage with investors and showcase their commercial-stage bioelectronic medicine and wellness solutions.
Details
News Market Reaction – ECOR
The recorded move for ECOR in the trading session of this news was -1.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s CEO, Dan Goldberger, is scheduled to participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference August 12 - 13, 2024. Please contact Needham to schedule a 1x1 meeting.
In addition, Brian Posner, CFO of electroCore, Inc. is scheduled to attend the 44th Annual Canaccord Genuity Growth Conference taking place at InterContinental Hotel in Boston, MA. electroCore will host 1x1 investor meetings on August 13, 2024. Please contact Canaccord Genuity to schedule a 1x1 meeting.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.